Longitudinal Associations Between Exclusive and Dual Use of Electronic Nicotine Delivery Systems and Cigarettes and Self-Reported Incident Diagnosed Cardiovascular Disease Among Adults
Nicotine & Tobacco Research · 2023
DOI: 10.1093/ntr/ntac182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nicotine & Tobacco Research, 2023. Verfasst von Jana L Hirschtick und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Cardiovascular Diseases, Tobacco Products, Myocardial Infarction. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
Introduction
The cardiovascular health effects of electronic nicotine delivery systems (ENDS) use are not well characterized, making it difficult to assess ENDS as a potential harm reduction tool for adults who use cigarettes. Aims and Methods Using waves 1–5 of the Population Assessment of Tobacco and Health Study (2013–2019), we analyzed the risk of self-reported incident diagnosed myocardial infarction (MI; 280 incident cases) and stroke (186 incident cases) associated with ENDS and/or cigarette use among adults aged 40 + using discrete time survival models. We employed a time-varying exposure lagged by one wave, defined as exclusive or dual established use of ENDS and/or cigarettes every day or some days, and controlled for demographics, clinical factors, and past smoking history.
Results
The analytic samples (MI = 11 031; stroke = 11 076) were predominantly female and non-Hispanic White with a mean age of 58 years. At baseline, 14.2% of respondents exclusively smoked cigarettes, 0.6% exclusively used ENDS, and 1.0% used both products. Incident MI and stroke were rare during follow-up (< 1% at each wave). Compared to no cigarette or ENDS use, exclusive cigarette use increased the risk of MI (aHR 1.99, 95% CI = 1.40–2.84) and stroke (aHR 2.26, 95% CI = 1.51–3.39), while exclusive ENDS use (MI: aHR 0.61, 95% CI = 0.12–3.04; stroke: aHR 1.74, 95% CI = 0.55–5.49) and dual use (MI: aHR 1.84, 95% CI = 0.64–5.30; stroke: aHR 1.12, 95% CI = 0.33–3.79) were not significantly associated with the risk of either outcome.
Conclusions
Compared to non-use, exclusive cigarette use was associated with an increased risk of self-reported incident diagnosed cardiovascular disease over a 5-year period, while ENDS use was not associated with a statistically significant increase in the outcomes.
Implications
Existing literature on the health effects of ENDS use has important limitations, including potential reverse causation and improper control for cigarette smoking. We accounted for these issues by using a prospective design and adjusting for current and former smoking status and cigarette pack-years. In this context, we did not find that ENDS use was associated with a statistically significant increase in self-reported incident diagnosed myocardial infarction or stroke over a 5-year period. While more studies are needed, this analysis provides an important foundation and key methodological considerations for future research on the health effects of ENDS use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
- Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA.
- Pulmonary Clinic, Department of Internal Medicine, University of Michigan Health System, Northville, MI, USA.
- Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA.
- Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., USA.
ORCID-Profile: Jana L Hirschtick, Akash Patel, Douglas Arenberg, Irina Bondarenko, David T Levy, Jihyoun Jeon, Rafael Meza, Nancy L Fleischer
Förderung
- NCI NIH HHS
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Hirschtick, J. L., Cook, S., Patel, A., Barnes, G. D., Arenberg, D., Bondarenko, I., Levy, D. T., Jeon, J., Jimenez Mendoza, E., Meza, R., & Fleischer, N. L. (2023). Longitudinal Associations Between Exclusive and Dual Use of Electronic Nicotine Delivery Systems and Cigarettes and Self-Reported Incident Diagnosed Cardiovascular Disease Among Adults. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntac182
Vancouver
Hirschtick JL, Cook S, Patel A, Barnes GD, Arenberg D, Bondarenko I, et al. Longitudinal Associations Between Exclusive and Dual Use of Electronic Nicotine Delivery Systems and Cigarettes and Self-Reported Incident Diagnosed Cardiovascular Disease Among Adults. Nicotine & Tobacco Research. 2023. doi:10.1093/ntr/ntac182
BibTeX
@article{Hirschtick2023,
author = {Hirschtick, Jana L and Cook, Steven and Patel, Akash and Barnes, Geoffrey D and Arenberg, Douglas and Bondarenko, Irina and Levy, David T and Jeon, Jihyoun and Jimenez Mendoza, Evelyn and Meza, Rafael and Fleischer, Nancy L},
title = {Longitudinal Associations Between Exclusive and Dual Use of Electronic Nicotine Delivery Systems and Cigarettes and Self-Reported Incident Diagnosed Cardiovascular Disease Among Adults},
journal = {Nicotine & Tobacco Research},
year = {2023},
doi = {10.1093/ntr/ntac182}
}
EUVIMED